Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 May 18;18(5):e0285803. doi: 10.1371/journal.pone.0285803

Coping with the mental health impact of COVID–19: A study protocol for a multinational longitudinal study on coping and resilience during the COVID-19 pandemic

Insa Backhaus 1,, Felix Sisenop 2,, Edvaldo Begotaraj 3, Marija Jevtic 4,5, Simone Marchini 6, Alessandro Morganti 7, Mihail Cristian Pirlog 8, Matej Vinko 9, Milica P Kusturica 10, Jutta Lindert 2,11,*; the COPERS consortium
Editor: Chalachew Kassaw Demoze12
PMCID: PMC10194934  PMID: 37200282

Abstract

Background

Mental health is challenged due to serious life events such as the COVID-19 pandemic and can differ by the level of resilience. National studies on mental health and resilience of individuals and communities during the pandemic provide heterogeneous results and more data on mental health outcomes and resilience trajectories are needed to better understand the impact of the pandemic on mental health in Europe.

Methods

COPERS (Coping with COVID-19 with Resilience Study) is an observational multinational longitudinal study conducted in eight European countries (Albania, Belgium, Germany, Italy, Lithuania, Romania, Serbia, and Slovenia). Recruitment of participants is based on convenience sampling and data are gathered through an online questionnaire. gathering data on depression, anxiety, stress-related symptoms suicidal ideation and resilience. Resilience is measured with the Brief Resilience Scale and with the Connor-Davidson Resilience Scale. Depression is measured with the Patient Health Questionnaire, Anxiety with the Generalized Anxiety Disorder Scale and stress-related symptoms with the Impact of Event Scale Revised- Suicidal ideation is assessed using item 9 of the PHQ-9. We also consider potential determinants and moderating factors for mental health conditions, including sociodemographic characteristics (e.g., age, gender), social environmental factors (e.g., loneliness, social capital) and coping strategies (e.g., Self-efficacy Belief).

Discussion

To the best of our knowledge, this is the first study to multi-nationally and longitudinally determine mental health outcomes and resilience trajectories in Europe during the COVID-19 pandemic. The results of this study will help to determine mental health conditions during the COVID-19 pandemic across Europe. The findings may benefit pandemic preparedness planning and future evidence-based mental health policies.

Introduction

With the spread of the COVID-19 pandemic, living on a day-to-day basis has become a challenge for many individuals worldwide. Since the official recognition of the pandemic in March 2020, more than five million people have died due to COVID-19 worldwide (as of December 2021) and at least 262.000.000 people have been infected [1]. In addition to the physical health impact of the pandemic, impacts on mental health, such as a higher risk of anxiety, elevated suicidal ideation and increased worries, have been reported in China [2], the USA [3] and Europe [4, 5]. Stressors put forward to negatively affect mental health include social isolation, loneliness, fear of contagion, interruption of healthcare services, loss of income, and loss of employment [5]. During the course of the pandemic, concerns have also been raised about the unequal distribution of mental health problems. While some groups seem to be more resilient, other groups are more vulnerable to the psychological impacts of the pandemic [6, 7], including children and adolescents [8, 9], people facing job insecurity [8] and people with pre-existing mental disorders [10].

Resilience has become an important concept in explaining differences in mental health when experiencing stressful life events [11, 12]. Essentially, resilience describes the ability to withstand setbacks, adapt positively, and bounce back from adverse life events such as disasters [13]. Scientific evidence shows that individuals with greater resilience respond more adequately to both natural and man-made disasters than individuals with lower resilience [14]. While research about the importance of resilience for mental health during the pandemic is emerging, it remains unclear, which factors promote or decrease resilience in times of crisis [1517]. Researchers from the USA and China, for instance, found that individual and family resilience are associated with mental health [16]. However, the authors did not investigate factors that may contribute to resilience. Currently, research examining determinants of resilience is only available from before the COVID-19 pandemic. A pre-pandemic study from Japan, for instance, points towards an association between social capital and resilience in Japan [18]. However, determinants of resilience may be situation-dependent and vary between countries and different population groups. In addition, resilience has been suggested to change over time as a result of personal development or one’s interaction with the environment [19, 20], but at present, most research on resilience uses cross-sectional data that does not allow the investigation of change over time. Moreover, current measures to contain the spread of COVID-19, such as lockdown, quarantine, and contact restriction, may complicate matters even further as they have changed people’s social behavior and social activities overnight. Factors such as feeling lonely and depressed during the lockdown as well as enhanced anxiety and suicidal ideation, may negatively affect resilience [21]. Very recent research from Panzeri and colleagues (2021), showed that COVID-19-anxiety, intolerance of uncertainty and loneliness hindered resilience [21]. Thus, a range of factors may promote or hinder resilience and consequently affect mental health.

Given that to date, only a very few studies assess factors that facilitate or hinder resilience, COPERS (Coping with COVID-19 with Resilience study) was developed. COPERS is a multinational longitudinal study among eight European countries that aim to investigate how mental-health outcomes vary between countries and to identify determinants of resilience and resilience trajectories over time. The findings will be important, as understanding, which factors foster resilience and mental health can help to inform effective health and social policies.

Objective, aims and hypotheses

The specific aims of COPERS are to (1) investigate the prevalence rate of depression, suicidal ideation and stress related symptoms over the course of the pandemic and whether the prevalence rate varies between European countries; (2) to identify factors that can facilitate or hinder resilience and to identify resilience trajectories; and (3) to determine how resilience is linked to mental health during the COVID-19 pandemic. Our main hypotheses are:

  1. We hypothesize that prevalence rate of depression, suicidal ideation and stress-related symptoms such as anxiety, increase over the course of the pandemic.

  2. We hypothesize that prevalence rates of depression, suicidal ideation and stress-related symptoms such as anxiety, vary between countries.

  3. We hypothesize that factors such as one’s socioeconomic position, social support, social capital, loneliness, alcohol consumption, and exposure to the COVID-19 pandemic are associated with resilience trajectories.

  4. We hypothesize that participants of a higher socioeconomic position and with a greater level of social capital and social support are less likely to experience poor mental health outcomes (e.g., depression, suicidal ideation and stress-related symptoms), whereas participants of a lower socioeconomic position and with greater levels of loneliness, higher levels of alcohol consumption and exposure to a greater pandemic burden are more likely to experience poor mental health outcomes (e.g., depression, suicidal ideation and stress-related symptoms).

Methods

COPERS is a non-funded, multinational longitudinal study and is run as a European collaborative research project composed by members of the EUPHA (European Public Health Association) public mental health group. It is led by researchers based at the University of Applied Sciences Emden/Leer in Germany, who have previously designed and delivered several projects across the European Union.

Study population

The sample consists of participants aged 18 years and older from Albania, Belgium, Germany, Italy, Lithuania, Romania, Serbia and Slovenia. To be eligible for the study, the potential participants must satisfy the following criteria:

  • Person must be aged 18 years or older

  • Person must have access to internet

  • Person must be able to provide informed consent online using the study website

  • Person must be proficient in one of the following languages: Albanian, Dutch, English, French, German, Italian, Lithuanian, Romanian, Slovenian, and Serbian.

Recruitment and study procedure

In all countries, recruitment and sampling approaches are based on an opportunistic, convenience–pandemic-specific sampling approach. In the present context of a pandemic, opportunistic sampling means using snowball sampling and following a purposive sampling approach using a diversity of pandemic-appropriate recruitment strategies. In the present study, the recruitment strategies include recruitment through homepages, professional associations, homepages of the participating institutions, social media and its services, press and media releases, and direct personal contacts. A complete list detailing the sampling strategies in each country is provided in the supplemental materials.

Prior to participating in the study, all potential participants are asked to complete an informed consent question embedded on the first page of the online survey. In case the respondents agree to participate in the study (i.e., entered “Yes” to the consent question), they can fill out the survey and a further invitation will be sent to collect data on the second and third wave. Respondents who disagree to participate in the study (i.e., entered “No” to the consent question) are directly transferred to the end of the survey. Participation is voluntary and can be withdrawn at any time.

Data collection

For the proposed study, a self-administered online survey will be applied. The survey will be comprised of four parts. The first part will collect sociodemographic information (e.g., age, gender, degree of education). The second part will investigate mental health (e.g., depression) and the third part will gather information on resilience trajectories. The final part will gather information on possible determinants of resilience, mental health and moderating factors such as social capital, general self-efficacy, alcohol use and loneliness. The survey is predominantly based on previously standardized and validated instruments and will include only a few self-developed COVID-19 specific questions. The choice of the instruments is based on appropriateness for the context, reliability, and validity.

Primary outcomes

Resilience

Resilience is defined as the ability to adapt to a changing situation and changing circumstances in the physical and social environment [22]. Accordingly, resilience will be assessed with two measures, using the Brief Resilience Scale (BRS) and the Connor-Davidson Resilience Scale (CD-RISC) [23]. The BRS was created to measure the ability to bounce back or recover from stress and is a valid and reliable tool for assessing resilience [24]. The BRS uses six items to assess resilience, based on a Likert agreement scale ranging from 1 (strongly disagree) to 5 (strongly agree) [24]. The CD-RISC is one of the most widely used scales to measure psychological resilience. It includes 25 items rated on a five-point Likert scale and range from 0 (not true at all) to 4 (true nearly all the time). Possible scores range from 0 to 100. The CD-RISC has been shown to predict both physical and mental health-related quality of life and to be of good reliability and validity [23]. Both the BRS and the CD-RISC are available in the respective survey languages applied in this study.

Depression and suicidal ideation

The primary mental health outcome is depression, measured with the Patient Health Questionnaire (PHQ-9), a multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression [25]. The PHQ-9 is a depression assessment tool, which scores each of the 9 DSM-IV criteria from 0 (not at all) to 3 (nearly every day). PHQ-9 cut-off scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression, respectively. The instrument yields scores ranging from 0 to 27, with higher scores indicating more severe depressive symptoms [26]. The assessment of suicidal thoughts will be based on item 9 of the PHQ-9. Item 9 of the PHQ-9 asks respondents to indicate if they have had thoughts of hurting themselves in some way or thoughts that they would be better off dead. Item 9 of the PHQ-9 is a robust predictor of suicide attempts [27]. Generally, the PHQ-9 has been shown to be a valid and reliable measurement tool for depression across European countries [25, 28] and has been translated into Dutch, French, German, Italian, Lithuanian, Romanian, and Serbian [29]. To be able to use the PHQ-9 in Albania and Slovenia; the tool was translated using the forward-backward translation approach.

Stress symptoms

The Impact of Event Scale Revised (IES-R) will be used for measuring stress [30]. The IES-R is a 22-item self-reported measure that assesses subjective distress caused by traumatic events. The IES-R has been translated into many languages including Germany, French, and Italian. A team of researchers translated the IES-R into Albania; Dutch, Lithuanian, Romanian, Slovenia and Serbian using the forward-backward translation approach.

Anxiety

Symptoms of anxiety will be measured using the generalized anxiety disorder 7 (GAD-7). The GAD-7 is a seven-item self-administered scale with a total score between 0 to 21. Higher scores indicate higher severity of anxiety (0–4 = minimal, 5–9 = mild, 10–14 = moderate and 15–21 = severe) [31]. The GAD-7 has been translated into Dutch, French, German, Italian, Lithuanian and Romanian [29]. Given the GAD-7 is not available in Albanian, Slovenian and Serbian, the forward-backward translation approach was applied to translate the tool into the respective languages.

Determinants of resilience, mental health and stress

A variety of determinants have been linked to resilience, mental health and stress, and have been reported to contribute to the association between stressful life events and mental health. These include, among others, sociodemographic factors, social capital, anxiety and loneliness. These determinants are also measured in the present study, as described below.

Sociodemographic data

The sociodemographic data will be collected on age, gender, living environment during the pandemic, educational level, occupational status, income, having children and marital status.

Social capital

Social capital that has been defined as “connections among individual social networks and the norms of reciprocity and trustworthiness that arise from them” [32], has been linked to mental health [33]. A growing body of literature suggests that in times of crisis, higher levels of social capital can enhance an individual’s ability to respond and recover from such crises, thus positively influencing resilience and mental health. The present study will focus particularly on cognitive social capital, which will be assessed using items drawn from the World Bank Integrated Questionnaire to Measure Social Capital (IQ-SC), a psychometric validated instrument [34].

Loneliness

The revised UCLA (University of California, Los Angeles) Loneliness Scale was used to measure perceived loneliness. The scale includes 20 items to measure subjective feelings of loneliness and has been shown to have good validity and reliability [35]. Participants are asked to rate items on a scale from 0 (I never feel this way) to 3 (I often feel this way) [35]. The tool has been validated in many different countries and translations in various languages exist [36, 37].

Alcohol consumption

Alcohol consumptions will be explored using the Alcohol Use Disorders Identification Test Concise (AUDIT-C) [38]. The AUDIT-C consists of the first three items of the full AUDIT (Alcohol Use Disorder Identification Test) and measures the typical frequency of alcohol consumption, the usual quantity per occasion, and the frequency of heavy episodic drinking [38]. The AUDIT-C has been found to be valid and reliable across various settings and different racial/ethnic groups and has been translated into various languages [39, 40].

COVID-19 burden

To explore specific COVID-19 pandemic-related factors, a set of self-developed COVID-19 pandemic-specific items (drawing from our expertise) will be included in the survey. The items will gather information on contamination anxiety, compliance with public health measures and separation of loved ones.

Statistical methods

Descriptive and inferential statistics will be applied to confirm or reject our hypotheses. To investigate prevalence rates of depression, suicidal ideation and stress-related symptoms such as anxiety as well as differences in prevalence rates between countries, descriptive statistics will be applied. To assess the association between social capital, loneliness and resilience as well as between resilience and mental health outcomes multilevel logistic regression analyses will be conducted. To identify moderating and mediating factors moderation and mediation analyses will be applied. Sensitivity analyses (excluding e.g., high-income countries) will contribute to a better understanding of the generalizability of our findings. More specifically, every measurement point, starting from the baseline data, will be analyzed cross-sectionally and longitudinally concerning the objectives of COPERS. To examine resilience trajectories linear, logistic and multinomial logistic regression analyses, will be conducted. Furthermore, latent growth curve analyses in the framework of structural equation modelling analyses will be conducted when testing which factors predict changes in resiliency and mental health trajectories. Furthermore, to simultaneously control for many variables that potentially confound the relationship between mental health and resilience, propensity score matching will be applied [41]. Propensity score matching offers the advantage of ensuring the baseline distribution of confounders between groups, which can increase group comparability. In addition, a multilevel analytical approach will be used to determine the various extrinsic and intrinsic influences on health and development.

Furthermore, sex, gender, age, and diversity are considered at all stages of the planned project. Wherever possible, a respective subgroup analysis will be performed. For instance, if possible, regression models will be run separately for different age groups. Data will be collected at different time points and loss of follow-up, drop-out and incompleteness are to be expected. The survey will be distributed at different time points. A sensitivity analysis will be used to assess how different time points may have affected the outcomes. All analyses will be performed in IBM SPSS version 26.0 and Stata version 15.0.

Methods to handle protocol non-adherence and any statistical methods to handle missing data

Descriptive statistics will be generated for two categorical variables: (1) full sample analyzed and (2) missing data. Missing data may lead to bias and loss of information in epidemiological research. If more than 15% of data are missing, multiple data imputation will be performed. In order to assess the potential risk of bias, we will perform a sensitivity analysis using the imputed data set.

General ethical aspects

This study will adhere in all stages of the project to the ethical principles of informed consent, voluntary participation, do no harm, confidentiality, anonymity and only assess relevant components. In practice, the study will (a) obtain informed consent from potential research participants; (b) minimize the risk of harm to participants; (c) protect their anonymity and confidentiality; (d) avoid using deceptive practices; and (e) give participants the right to withdraw from the research. This study will follow the Nuremberg Code (1947) and the Helsinki code (1964) at all stages of the research project. Our research does not include vulnerable populations (e.g., prisoners, institutionalized persons). The Ethics Committee of the University of Emden/Leer approved the COPERS and all Institutional Review Boards (IRB) of the participating sites. The survey will involve multiple sensitive questions, including ones about depressive symptoms and suicidal ideation. Therefore, answering may cause discomfort for participants or distress in respondents with pre-existing emotional vulnerabilities. Participants will be provided with information about counselling centers. Furthermore, participants do not have to answer questions they feel uncomfortable with and can stop compilation at any time.

Any important modification to the protocol that may impact on the conduct of the study, including changes of study objectives, study design, study procedures, or significant administrative aspects, will be communicated to the ethical committees of all participating project partners.

Study status and timeline

COPERS is currently on-going, and the timeline and major milestones are shown in Fig 1. Participant enrollment started in 2020 and data collection for Wave 1 commenced in August 2020. Data collection for Wave 2 is planned for the summer 2021 and data collection for Wave 3 is expected to start at the beginning of 2022.

Fig 1. COPERS timeline.

Fig 1

Discussion

To the best of our knowledge, there are no comprehensive longitudinal studies on resilience and mental health during the COVID-19 pandemic in the European region so far. COPERS has been designed as the first multinational longitudinal prospective study in eight countries in Europe, assessing mental health and resilience trajectories during the COVID-19 pandemic. Therefore, it makes two important contributions: First, COPERS is the first study to document resilience trajectories and mental health outcomes during the COVID-19 pandemic in a multinational sample from middle-income to high-income countries across Europe. In addition, COPERS is among the first studies to include Eastern European countries such as Albania, Serbia and Lithuania, for which very limited data about mental health and resilience are available. Second, with its longitudinal and multilevel design, it will provide reliable information on changes in resilience trajectories and mental health outcomes and contextual and macro level factors possibly influencing mental health and resilience of the European population during the pandemic. A longitudinal and multilevel design is particularly important because, to date, the majority of studies that have examined resilience applied a cross-sectional design and were unable to investigate the ways in which resilience changes and interacts with events over time.

Implications for research and public health professionals

The COVID-19 pandemic has hit the world in unprecedented ways and has led to a stark increase in mental ill-health. The results of this study will be of importance for researchers and public health professional for at least two reasons: First, the COVID-19 pandemic is unlikely the last crisis and pandemic. To promote as well as to prevent declining mental health in times of a crisis, it is therefore of great importance to identify factors that can foster resilience and promote mental health ahead of a crisis. By examining resilience trajectories and factors associated with mental health, the results of this study offers novel knowledge of modifiable factors can be helpful for decision-making of public health professional, health professionals, and policymakers to prepare for other disease outbreaks and pandemics, where containment measures are necessary. Second, the study examines the underpinnings of resilience and the findings of this study may help to build resilient communities and to inform pandemic preparedness planning as well as health and social policies.

Strengths and limitations

Despite the valuable information provided by COPERS, some limitations need to be mentioned. First, the findings will be based on a convenience sample. Therefore, it is possible that the sample is not representative of an entire country or region, limiting the generalizability of the results of the survey to the populations as a whole. Second, given that the study is a web-based survey, it is possible that people who do not have access to the internet or do not know how to use digital technology will be underrepresented (e.g., elderly). Consequently, selection bias is possible. Third, mental health outcomes are assessed using self-reported measures and therefore information or recall bias cannot be ruled out. Despite the good reliability and validity of the PHQ-9 and the GAD-7, the involvement of an assessment by a clinician is always preferable when assessing mental health.

Conclusion

To conclude, COPERS is a unique study and one of the largest study of its kind in Europe to collect longitudinal data on resilience and mental health during the COVID-19 pandemic. Results of the study will improve the understanding of the ways in which resilience and mental health are influenced by individual, situational and contextual factors. The findings of this study can help to build resilient communities and to inform pandemic preparedness planning as well as health and social policies.

Supporting information

S1 Table. Instruments used in COPERS.

(DOCX)

S1 File. Genehmigung ethikantrag COPERS.

(PDF)

S2 File. P2021-142- accord CE.

(PDF)

S3 File. POLIMI IRB approval.

(PDF)

S4 File. UMFCV IRB COPERS.

(PDF)

Acknowledgments

The COPERS consortium consists of Insa Backhaus, Edvaldo Begotaraj, Stefano Capolongo, Mauro G. Carta, Marija Jakubauskiene, Marija Jevtic, Milica P. Kusturica, Jutta Lindert, Alessandro Morganti, Mihail Cristian Pirlog, Andrea Rebecchi, Felix Sisenop, and Matej Vinko.

For the COPERS consortium

Stefano Capolongo (Department of Architecture, Built Environment and Construction Engineering (DABC), Design and Health Lab, Politecnico di Milano, Milan, Italy), Marija Jakubauskiene (Faculty of Medicine, Vilnius University, Vilnius, Lithuania), Vladimir Nakov (Department of Mental Health, National Center of Public Health and Analyses, Sofia, Bulgaria),

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

Authors received no specific funding for this work.

References

  • 1.World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. 2020 [cited 8 Jul 2020]. https://covid19.who.int
  • 2.Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020;288: 112954. doi: 10.1016/j.psychres.2020.112954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Czeisler MÉ. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic—United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69. doi: 10.15585/mmwr.mm6932a1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pierce M, Hope H, Ford T, Hatch S, Hotopf M, John A, et al. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiatry. 2020;0. doi: 10.1016/S2215-0366(20)30308-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Varga TV, Bu F, Dissing AS, Elsenburg LK, Bustamante JJH, Matta J, et al. Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: A longitudinal analysis of 200,000 Western and Northern Europeans. Lancet Reg Health—Eur. 2021;2: 100020. doi: 10.1016/j.lanepe.2020.100020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wachtler B, Michalski N, Nowossadeck E, Diercke M, Wahrendorf M, Santos-Hövener C, et al. Socioeconomic inequalities and COVID-19 –A review of the current international literature. 2020 [cited 7 Jul 2021]. [DOI] [PMC free article] [PubMed]
  • 7.Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health. 2020;74: 964–968. doi: 10.1136/jech-2020-214401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ganson KT, Tsai AC, Weiser SD, Benabou SE, Nagata JM. Job Insecurity and Symptoms of Anxiety and Depression Among U.S. Young Adults During COVID-19. J Adolesc Health Off Publ Soc Adolesc Med. 2021;68: 53–56. doi: 10.1016/j.jadohealth.2020.10.008 [DOI] [PubMed] [Google Scholar]
  • 9.Meherali S, Punjani N, Louie-Poon S, Abdul Rahim K, Das JK, Salam RA, et al. Mental Health of Children and Adolescents Amidst COVID-19 and Past Pandemics: A Rapid Systematic Review. Int J Environ Res Public Health. 2021;18: 3432. doi: 10.3390/ijerph18073432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Murphy L, Markey K, O’ Donnell C, Moloney M, Doody O. The impact of the COVID-19 pandemic and its related restrictions on people with pre-existent mental health conditions: A scoping review. Arch Psychiatr Nurs. 2021;35: 375–394. doi: 10.1016/j.apnu.2021.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Färber F, Rosendahl J. The Association Between Resilience and Mental Health in the Somatically Ill. Dtsch Ärztebl Int. 2018;115: 621–627. doi: 10.3238/arztebl.2018.0621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Siriwardhana C, Ali SS, Roberts B, Stewart R. A systematic review of resilience and mental health outcomes of conflict-driven adult forced migrants. Confl Health. 2014;8: 13. doi: 10.1186/1752-1505-8-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Killgore WDS, Taylor EC, Cloonan SA, Dailey NS. Psychological resilience during the COVID-19 lockdown. Psychiatry Res. 2020;291: 113216. doi: 10.1016/j.psychres.2020.113216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bonanno GA, Galea S, Bucciarelli A, Vlahov D. Psychological Resilience After Disaster: New York City in the Aftermath of the September 11th Terrorist Attack. Psychol Sci. 2006;17: 181–186. doi: 10.1111/j.1467-9280.2006.01682.x [DOI] [PubMed] [Google Scholar]
  • 15.Verdolini N, Amoretti S, Montejo L, García-Rizo C, Hogg B, Mezquida G, et al. Resilience and mental health during the COVID-19 pandemic. J Affect Disord. 2021;283: 156–164. doi: 10.1016/j.jad.2021.01.055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chan ACY, Piehler TF, Ho GWK. Resilience and mental health during the COVID-19 pandemic: Findings from Minnesota and Hong Kong. J Affect Disord. 2021;295: 771–780. doi: 10.1016/j.jad.2021.08.144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rossi R, Jannini TB, Socci V, Pacitti F, Lorenzo GD. Stressful Life Events and Resilience During the COVID-19 Lockdown Measures in Italy: Association With Mental Health Outcomes and Age. Front Psychiatry. 2021;12: 635832. doi: 10.3389/fpsyt.2021.635832 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gero K, Hikichi H, Aida J, Kondo K, Kawachi I. Associations Between Community Social Capital and Preservation of Functional Capacity in the Aftermath of a Major Disaster. Am J Epidemiol. 2020;189: 1369–1378. doi: 10.1093/aje/kwaa085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Southwick SM, Bonanno GA, Masten AS, Panter-Brick C, Yehuda R. Resilience definitions, theory, and challenges: interdisciplinary perspectives. Eur J Psychotraumatology. 2014;5: 25338. doi: 10.3402/ejpt.v5.25338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kim-Cohen J, Turkewitz R. Resilience and measured gene-environment interactions. Dev Psychopathol. 2012;24: 1297–1306. doi: 10.1017/S0954579412000715 [DOI] [PubMed] [Google Scholar]
  • 21.Panzeri A, Bertamini M, Butter S, Levita L, Gibson-Miller J, Vidotto G, et al. Factors impacting resilience as a result of exposure to COVID-19: The ecological resilience model. PLOS ONE. 2021;16: e0256041. doi: 10.1371/journal.pone.0256041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Masten AS, Motti-Stefanidi F. Multisystem Resilience for Children and Youth in Disaster: Reflections in the Context of COVID-19. Advers Resil Sci. 2020;1: 95–106. doi: 10.1007/s42844-020-00010-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Connor KM, Davidson JRT. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18: 76–82. doi: 10.1002/da.10113 [DOI] [PubMed] [Google Scholar]
  • 24.Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: Assessing the ability to bounce back. Int J Behav Med. 2008;15: 194–200. doi: 10.1080/10705500802222972 [DOI] [PubMed] [Google Scholar]
  • 25.Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16: 606–613. doi: 10.1046/j.1525-1497.2001.016009606.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Levis B, Benedetti A, Thombs BD. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365: l1476. doi: 10.1136/bmj.l1476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Rossom RC, Coleman KJ, Ahmedani BK, Beck A, Johnson E, Oliver M, et al. Suicidal Ideation Reported on the PHQ9 and Risk of Suicidal Behavior across Age Groups. J Affect Disord. 2017;215: 77–84. doi: 10.1016/j.jad.2017.03.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Arthurs E, Steele RJ, Hudson M, Baron M, Thombs BD, (CSRG) Canadian Scleroderma Research Group. Are scores on English and French versions of the PHQ-9 comparable? An assessment of differential item functioning. PloS One. 2012;7: e52028. doi: 10.1371/journal.pone.0052028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pfizer. Screener Overview: PHQ and GAD-7 Screeners. 2022; https://www.phqscreeners.com
  • 30.Weiss DS. The Impact of Event Scale: Revised. In: Wilson JP, Tang CS, editors. Cross-Cultural Assessment of Psychological Trauma and PTSD. Boston, MA: Springer US; 2007. pp. 219–238. [Google Scholar]
  • 31.Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166: 1092–1097. doi: 10.1001/archinte.166.10.1092 [DOI] [PubMed] [Google Scholar]
  • 32.Putnam RD. Bowling Alone: The Collapse and Revival of American Community. Simon and Schuster; 2001.
  • 33.Bassett E, Moore S. Social capital and depressive symptoms: The association of psychosocial and network dimensions of social capital with depressive symptoms in Montreal, Canada. Soc Sci Med. 2013;86: 96–102. doi: 10.1016/j.socscimed.2013.03.005 [DOI] [PubMed] [Google Scholar]
  • 34.Grootaert C, Narayan D, Nyhan Jones V, Woolcock M. Measuring Social Capital: An Integrated Questionnaire. The World Bank; 2004. http://documents.worldbank.org/curated/en/515261468740392133/pdf/281100PAPER0Measuring0social0capital.pdf
  • 35.Russell D, Peplau LA, Cutrona CE. The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. J Pers Soc Psychol. 1980;39: 472–480. doi: 10.1037//0022-3514.39.3.472 [DOI] [PubMed] [Google Scholar]
  • 36.Boffo M, Mannarini S, Munari C. Exploratory Structure Equation Modeling of the UCLA Loneliness Scale: A contribution to the Italian adaptation. TPM-Test Psychom Methodol Appl Psychol. 2012;19: 345–363. [Google Scholar]
  • 37.de Grâce G-R, Joshi P, Pelletier R. L’Échelle de solitude de l’Université Laval (ÉSUL): validation canadienne-française du UCLA Loneliness Scale. [The Laval University loneliness scale: A Canadian-French validation of the University of California at Los Angeles (UCLA) Loneliness Scale.]. Can J Behav Sci Rev Can Sci Comport. 1993;25: 12–27. doi: 10.1037/h0078812 [DOI] [Google Scholar]
  • 38.Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158: 1789–1795. doi: 10.1001/archinte.158.16.1789 [DOI] [PubMed] [Google Scholar]
  • 39.Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol Clin Exp Res. 2005;29: 844–854. doi: 10.1097/01.alc.0000164374.32229.a2 [DOI] [PubMed] [Google Scholar]
  • 40.Bazzo S, Battistella G, Riscica P, Moino G, Dal Pozzo G, Bottarel M, et al. Reliability of a self-report Italian version of the AUDIT-C questionnaire, used to estimate alcohol consumption by pregnant women in an obstetric setting. Riv Psichiatr. 2015;50: 89–94. doi: 10.1708/1872.20456 [DOI] [PubMed] [Google Scholar]
  • 41.VanderWeele T. The use of propensity score methods in psychiatric research. Int J Methods Psychiatr Res. 2006;15: 95–103. doi: 10.1002/mpr.183 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Chalachew Kassaw Demoze

21 Mar 2023

PONE-D-23-00090Coping with the mental health impact of COVID–19: a study protocol for a multinational longitudinal study on coping and resilience during the COVID-19 pandemicPLOS ONE

Dear Dr. Lindert,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 05 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Chalachew Kassaw Demoze

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in your Competing Interests section:  

"The authors declared that no competing interests exist."

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 

4. Please upload a copy of Figure 1, to which you refer in your text on page 12. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

Reviewer #2: Partly

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. It would be sounded for the paper to add an important components on the Abstract part as it is a very readable section.

2. While the paper to be sounded Grammar should be corrected especially tense change

3. Sample size calculation and sample size is not clear.

4. Mental health is very broad, so the author be specific from the variables of the studies; For example, the determinant of resilience, mental health and stress, as author put it.

5. The reasons why the study fails to address the finding relate to previous researches is not clear

Reviewer #2: The researchers conducted Coping with the mental health impact of COVID–19: a study protocol for a multinational longitudinal study on coping and resilience during the COVID-19 pandemic. I find that the the introduction is clear, I have a few remarks to improve the manuscript:

• Avoid subjective verbs We, I, Our in the document rather use the study, this study…

• Your hypotheses are not clearly written especially the third and fourth hypothesis, try to be more specific.

• Remove this sentence from inclusion criteria “Persons are not eligible to participate if they do not meet the inclusion criteria”

• Be care on some technical terms between multiple and multivariable terms. Re-correct it

• Add more important implications for health (individual and/or public), as well as health care, policy and for other researchers

• Why you impose language limits,

• Try to answer all of the objectives in clear manner since it is important?

• Make your discussion more strong.

• On conclusion part it is expected to an

• Unify the references

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Tilahun Bete

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.<quillbot-extension-portal></quillbot-extension-portal>

Attachment

Submitted filename: PLOS comments.docx

PLoS One. 2023 May 18;18(5):e0285803. doi: 10.1371/journal.pone.0285803.r003

Author response to Decision Letter 0


21 Apr 2023

Response letter

Dear Editorial Team and Reviewers,

on behalf of all the co-authors, I thank you very much for your interest in our work and for giving us the chance to revise the manuscript once more. You have brought up some very good points that will surely improve our manuscript. We have tried to do our best to respond to the points raised and we hope it will now be suitable for publication in the Plose One. Please find below your comments (in bold) and our replies.

The researchers conducted Coping with the mental health impact of COVID–19: a study protocol for a multinational longitudinal study on coping and resilience during the COVID-19 pandemic. I find that the introduction is clear. I have a few remarks to improve the manuscript:

Author response: Thank you very much for your comments. We have tried to improve our manuscript further.

Avoid subjective verbs We, I, Our in the document rather use the study, this study…

Author response: Thank you for this comment. We have now avoided subjective verbs.

Your hypotheses are not clearly written especially the third and fourth hypothesis, try to be more specific.

Author response: Thank you for this impotant comments. We have rephrased hypotheses 3 and 4. It reads as follows:

3. We hypothesize that factors such as one’s socioeconomic position, social support, social capital, loneliness, alcohol consumption, and exposure to the COVID-19 pandemic are associated with resilience trajectories.

4. We hypothesize that participants of a higher socioeconomic position and with a greater level of social capital and social support are less likely to experience poor mental health outcomes (e.g., depression, suicidal ideation and stress-related symptoms), whereas participants of a lower socioeconomic position and with greater levels of loneliness, higher levels of alcohol consumption and exposure to a greater pandemic burden are more likely to experience poor mental health outcomes (e.g., depression, suicidal ideation and stress-related symptoms).

Remove this sentence from inclusion criteria “Persons are not eligible to participate if they do not meet the inclusion criteria”

Author response: We have deleted this sentence from the manuscript.

Be careful on some technical terms between multiple and multivariable terms. Re-correct it

Author response: We have reviewed the methods section and corrected it where appropriate.

Add more important implications for health (individual and/or public), as well as health care, policy and for other researchers

Author response: We have revised the section for implications for health (individual and/or public), as well as health care, policy and for other researchers. To highlight the importance and the implications of the study we wrote an entire paragraph and this is now a single section in the discussion.

Why you impose language limits.

Author response: We restrict the language to the language of the participating countries and the language skills of collaborating researchers. This is a non-funded research project and providing the survey in additional languages is out of scope.

Try to answer all of the objectives in clear manner since it is important?

Author response: We have re-worded the objective to one so it is more in line with hypothesis one. We will try our best to answer all objectives through a careful data analysis once the study is completed.

Make your discussion more strong.

Author response: We have added the implications for health (individual and/or public), as well as health care, policy and for other researchers to the discussion.

On conclusion part it is expected to an

Author response: Please excuse us, but we do not fully understand this comment. We have done a careful English review.

Unify the references

Author response: We are sorry but we cannot unify the references.

Attachment

Submitted filename: Answer to reviewers_28012022_JL.docx

Decision Letter 1

Chalachew Kassaw Demoze

2 May 2023

Coping with the mental health impact of COVID–19: a study protocol for a multinational longitudinal study on coping and resilience during the COVID-19 pandemic

PONE-D-23-00090R1

Dear Dr. Lindert,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Chalachew Kassaw Demoze

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

It is better to include a conclusion part on the abstract section of the manuscript

It is better to re-write a manuscript with better English grammar

Reviewers' comments:

<quillbot-extension-portal></quillbot-extension-portal>

Acceptance letter

Chalachew Kassaw Demoze

9 May 2023

PONE-D-23-00090R1

Coping with the mental health impact of COVID–19: a study protocol for a multinational longitudinal study on coping and resilience during the COVID-19 pandemic

Dear Dr. Lindert:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Chalachew Kassaw Demoze

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Instruments used in COPERS.

    (DOCX)

    S1 File. Genehmigung ethikantrag COPERS.

    (PDF)

    S2 File. P2021-142- accord CE.

    (PDF)

    S3 File. POLIMI IRB approval.

    (PDF)

    S4 File. UMFCV IRB COPERS.

    (PDF)

    Attachment

    Submitted filename: Answer to reviewers_28012022_JL.docx

    Attachment

    Submitted filename: PLOS comments.docx

    Attachment

    Submitted filename: Answer to reviewers_28012022_JL.docx

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES